Thus, irrespective of the cell of origin, an NSC or a differentiated astrocyte, events that lead to loss of p16INK4a and p19ARF and constitutive signalling via EGFR, possibly leading to a loss of differentiation, eventually provoke highly malignant (high-grade) glioma. Here, CDKN2A is linked to glioma.